A Level Playing Field? Medicare Tries To Balance Transparency, Confidentiality With Drug Price Negotiations

 
• By Sarah Karlin-Smith
shredded paper
Medicare wants drug companies to keep confidential and later destroy materials related to a drug subject to government negotiations. • Source: Shutterstock

More from Pricing Debate

More from Market Access